TXG:NSD-10X Genomics Inc (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 27.48

Change

0.00 (0.00)%

Market Cap

USD 3.29B

Volume

2.39M

Analyst Target

USD 120.25
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-04 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
GEHC GE HealthCare Technologies Inc..

+0.55 (+0.68%)

USD 37.50B
HQY HealthEquity Inc

+0.81 (+1.03%)

USD 6.66B
RCM R1 RCM Inc

+0.12 (+0.97%)

USD 5.09B
PGNY Progyny Inc

+0.54 (+1.96%)

USD 3.05B
CERT Certara Inc

-0.39 (-2.37%)

USD 2.73B
GDRX Goodrx Holdings Inc

-0.58 (-7.20%)

USD 2.47B
PRVA Privia Health Group Inc

-0.10 (-0.59%)

USD 2.14B
PINC Premier Inc

-0.12 (-0.61%)

USD 2.08B
BTSG BrightSpring Health Services I..

+0.07 (+0.61%)

USD 1.81B
SDGR Schrodinger Inc

-0.14 (-0.61%)

USD 1.65B

ETFs Containing TXG

SGDJ Sprott Junior Gold Miners.. 4.87 % 0.57 %

+1.31 (+0.30%)

USD 0.12B
SGDM Sprott Gold Miners ETF 3.49 % 0.57 %

+0.68 (+0.30%)

USD 0.25B
ZGD:CA BMO Equal Weight Global G.. 2.96 % 0.61 %

+3.15 (+0.30%)

CAD 0.06B
AUCO:SW L&G Gold Mining UCITS ETF.. 2.79 % 0.00 %

+0.11 (+0.30%)

USD 0.15B
AUCO:LSE L&G Gold Mining UCITS ETF 2.59 % 0.00 %

+0.42 (+0.30%)

USD 0.14B
AUCP:LSE Legal & General UCITS ETF.. 2.59 % 0.00 %

+11.50 (+0.30%)

USD 0.14B
ARKG 0.00 % 0.75 %

N/A

N/A
PZC:CA 0.00 % 0.67 %

N/A

N/A
GOAU U.S. Global GO GOLD and P.. 0.00 % 0.60 %

+0.76 (+0.30%)

USD 0.10B
ETLX:F L&G Gold Mining UCITS ETF 0.00 % 0.00 %

N/A

USD 0.13B
ETLX:XETRA L&G Gold Mining UCITS ETF 0.00 % 0.00 %

+0.97 (+0.30%)

USD 0.13B

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -50.89% 15% F 8% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return -50.89% 15% F 8% B-
Trailing 12 Months  
Capital Gain -49.36% 41% F 19% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -49.36% 41% F 19% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 15.64% 82% B 76% C+
Dividend Return 15.64% 80% B- 74% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 75.56% 13% F 21% F
Risk Adjusted Return 20.70% 73% C 57% F
Market Capitalization 3.29B 94% A 85% B

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector